Skip to main content
Move the World.
What is AAV Gene Therapy

Lead Image by Andrew Brumagen

Genetic diseases were thought to be incurable — letters carved in stone (or on a double helix). But gene therapy could change all that.

From treating Duchenne muscular dystrophy, autism, or glaucoma, there has been a surge in the news surrounding gene therapy (type "gene therapy" into the Freethink search tool, and you'll see endless stories about medical breakthroughs).

The total number of completed or ongoing gene therapy clinical trials reached 4000 in February 2020. This type of treatment is on its way toward addressing some of the most severe and complicated ailments known to man. Gene therapy even shows promise for treating diseases like cancer or Huntington's disease — longstanding mysteries of medical science.

What Is Gene Therapy?

Instead of using medications or surgery, doctors can use gene therapy to fight diseases at their source. Gene therapy attempts to cure a disease, or boost the body's ability to combat a disease, by replacing a defective gene or adding a new gene.

The success of gene therapy all hinges on the ability to deliver that precious genetic cargo into the patient's cells safely. To do that, scientists use a "vector" as a delivery vessel for the genetic material. In most cases, that vector is a virus.

Scientists engineer an unwitting virus to act as a vector to deliver a therapeutic genetic payload.

We don't typically think fondly of viruses. Usually, they don't enter the human body to help. Instead, viruses like the flu or coronavirus make humans sick by inserting their genetic material into human cells and hijacking them. The cell reads the viral DNA (or RNA) and produces virus offspring, infecting other cells, repeating the process.

But, since viruses naturally deliver genetic material into a human cell, they are the most widely used vectors in gene therapy.

Scientists engineer an unwitting virus to act as a vector to deliver a therapeutic genetic payload. They strip the virus of its own genes and replace it with new genes. Once the virus transports its genetic cargo into tissues, the altered genes get to work — producing further instructions to treat the disease.

But the human body can recognize the virus as a foreign invader and launch an immune response — attempting to target and reject the virus.

Enter the adeno-associated viruses (AAV) — a small virus that has emerged as the most promising platform for gene therapy.

What Is AAV Gene Therapy and Why Is It Better?

These small, versatile viruses have several advantages over other gene therapy vectors.

First, despite their small size, they can carry a sizeable genetic payload. They are not known to cause many human diseases, and they can be designed to target particular types of cells or tissues. They cannot replicate on their own, so scientists can control how much gene therapy is delivered to the body.

The best part: they don't trigger a very large immune response like other viruses. A gene therapy trial in the 1990s that used an adenovirus (a kind of cold virus, different from AAVs) caused a deadly immune overreaction in one patient — and effectively ended gene therapy research in humans for a decade.

After that, researchers went back to the drawing board, looking for safer vectors. AAVs, because they don't cause disease and can't replicate, generally fly under the immune system's radar. These characteristics make them perfect vessels for gene therapy. And clinical trials have since shown that AAV gene therapy is safe and, for some diseases, effective.

Now that AAVs are established as gene therapy vectors, scientists are working to improve their delivery and create the next generation of AAV gene therapy.

Researchers have been successful with AAV gene therapy in the clinical setting. Currently, two FDA-approved gene therapy treatments use AAVs: Luxturna, which was approved in 2017 for a rare vision disorder, and Zolgensma, which was approved last year for spinal muscular atrophy.

But there are challenges to overcome. Because AAVs are viruses that people are naturally exposed to, many people have already developed antibodies against them. When a patient who has been previously exposed to an AAV receives AAV gene therapy, these antibodies could block the therapy.

Recently, a team of researchers figured out how to cloak the AVV to sneak past the immune system and deliver its gene therapy payload without triggering any immune response.

With the recent surge in AAVs as viral vectors and more clinical studies in the pipeline, we can expect to see new gene therapies that are safe and effective.

We'd love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected]

Up Next

Insects
Is Death by Pee Our Next Pesticide?
urine pesticide
Insects
Is Death by Pee Our Next Pesticide?
It may not be your number one idea, but having beetles pee themselves to death could be the next pesticide.

It may not be your number one idea, but having beetles pee themselves to death could be the next pesticide.

Agriculture
Plants Make Their Own Mini Weapon Launchers to Fight Off Fungus
natural fungicide
Agriculture
Plants Make Their Own Mini Weapon Launchers to Fight Off Fungus
Scientists engineered plants to stop fungus that causes grey mold. This could lead to natural fungicides that protect food crops without toxins.

Scientists engineered plants to stop fungus that causes grey mold. This could lead to natural fungicides that protect food crops without toxins.

Mars
Icelandic Rocks Hold Clues to Mars’ Ancient Climate
Mars climate
Mars
Icelandic Rocks Hold Clues to Mars’ Ancient Climate
Water once flowed on Mars. But was ancient Mars’s climate hot and wet, or dry and glacial? Iceland may hold the answer.

Water once flowed on Mars. But was ancient Mars’s climate hot and wet, or dry and glacial? Iceland may hold the answer.

Coronavirus
Why COVID-19 Patients Lose Their Sense of Smell
covid 19 loss of smell symptom
Coronavirus
Why COVID-19 Patients Lose Their Sense of Smell
Researchers have identified cells that are most susceptible to the novel coronavirus. They also support neurons associated with the sense of smell.

Researchers have identified cells that are most susceptible to the novel coronavirus. They also support neurons associated with the sense of smell.

Healthcare
New Health Wearable Measures Sweat to Track Your Mood
Wearable
Healthcare
New Health Wearable Measures Sweat to Track Your Mood
An app that works with a wearable wrist sensor to track how much a person sweats could change how we harness the power of biodata in the future.

An app that works with a wearable wrist sensor to track how much a person sweats could change how we harness the power of biodata in the future.

Future of Medicine
This Ultrasound Connects to an iPhone to Help Catch COVID-19
Portable Ultrasound Machine
Future of Medicine
This Ultrasound Connects to an iPhone to Help Catch COVID-19
Ultrasound can be a useful diagnostic tool for COVID-19. A portable ultrasound machine called the Butterfly iQ may make it safer.

Ultrasound can be a useful diagnostic tool for COVID-19. A portable ultrasound machine called the Butterfly iQ may make it safer.

Dispatches
New Evidence Suggests Viruses May Trigger Alzheimer’s
New Evidence Suggests Viruses May Trigger Alzheimer’s
Dispatches
New Evidence Suggests Viruses May Trigger Alzheimer’s
For the first time in a long time, there's a new direction for potential Alzheimer's treatments.

For the first time in a long time, there's a new direction for potential Alzheimer's treatments.

Dispatches
How Coffee Could Treat Diabetes
How Coffee Could Treat Diabetes
Dispatches
How Coffee Could Treat Diabetes
Someday, diabetics could use caffeine to trigger insulin production, thanks to specially designed kidney cells.

Someday, diabetics could use caffeine to trigger insulin production, thanks to specially designed kidney cells.

Superhuman
Superhuman Trailer
Superhuman Trailer
Watch Now
Superhuman
Superhuman Trailer
Join us as we meet the innovators building our superhuman future.
Watch Now

Superhuman is a Freethink original series about the amazing advances in medical innovation that are making the present look more like a sci-fi depiction of the future. Join us as we meet the engineers, entrepreneurs, doctors and patients who are giving people a new lease on life today, while building our superhuman future of tomorrow.